“…From 2,924 retrieved studies, 51 remained for assessment. At extraction data stage, we excluded 18 more studies because of absence or too restrictive diagnostic criteria (Aass, Albander, Assenden, Tollefsen, & Gjermo, ; Belhaissi, Cherkaoui, Laporte, & Miquel, ; Cappelli, Ebersole, & Kornman, ; Gjermo, Bellini, Santos, Martins, & Ferracyoli, ; Kumar, Altamash, & Qamruddin, ; Van der Velden et al, ; Wagaiyu & Wagaiyu, ; Yoshida, Fujiwara, Ooshima, & Sobue, ) or due to a duplicate study (Saxby, ) or a study reporting data from previous studies (Oliver, Brown, & Löe, ). We also excluded three studies having an inadequate study design (Fatema & Desai, ; Nassar, Afifi, & Deprez, ; Rhee, Sekhon, & Boehm, ) and one more study with no reported global prevalence (Albandar, Brown, & Löe, ).…”